Educational information only — not medical advice. Most peptides here are not FDA-approved.
MyPeps
Calculator
← The Peps Report

Episode 1 · October 9, 2026 · 3:41

Reported HHS stopgap could open a path to unapproved peptides

A reported HHS stopgap could let pharmacies sell some unapproved peptides. Brock breaks down what's confirmed, the thin evidence on KPV, MOTS-c, Semax and epithalon, and the FDA crackdown.

Spotify ↗RSS feed
Download MP3

Show notes

A reported HHS stopgap could open a path for compounding pharmacies to dispense some peptides that aren't FDA-approved, while formal rules are written. Brock walks through what's confirmed (the July advisory vote), what's only reported, how thin the human evidence is for the peptides involved, and why the FDA is still cracking down on "research use only" sellers.

Read the full post: Reported HHS stopgap could open a path to unapproved peptides

In this episode

  • 00:00 Cold open
  • 00:16 The reported HHS stopgap
  • 00:43 What the FDA panel actually voted
  • 01:14 KPV, MOTS-c, Semax and epithalon: the evidence
  • 02:09 Safety and the FDA's warning letters
  • 02:53 Quick hit: Lilly and retatrutide
  • 03:08 What this means for you

Peptides covered

Sources

  1. HHS plans stopgap to allow sales of some unapproved peptides: Washington Post — Becker's Hospital Review, Oct. 8, 2026. https://www.beckershospitalreview.com/glp-1s/hhs-plans-stopgap-to-allow-sales-of-some-unapproved-peptides-washington-post/
  2. FDA balances peptide policy with enforcement against unlawful peptide sellers — Sheppard Mullin, Sept. 18, 2026. https://www.sheppard.com/insights/blogs/fda-balances-peptide-policy-with-enforcement-against-unlawful-peptide-sellers
  3. ECRI, ISMP warn of safety risks tied to peptides — Becker's Hospital Review, May 6, 2026. https://www.beckershospitalreview.com/pharmacy/ecri-ismp-warn-of-safety-risks-tied-to-peptides/
  4. NuScience Peptides LLC warning letter 733652 — FDA, Aug. 24, 2026. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nuscience-peptides-llc-733652-08242026
  5. RUO-ined: five peptide vendors learn that research use only is not a legal strategy — ArentFox Schiff, Sept. 18, 2026. https://www.afslaw.com/perspectives/alerts/ruo-ined-five-peptide-vendors-learn-research-use-only-not-legal-strategy
  6. 5 things to know if retatrutide is classified as a biologic — AJMC, Oct. 7, 2026. https://www.ajmc.com/view/5-things-to-know-if-retatrutide-is-classified-as-a-biologic

Educational information, not medical advice.

Read the article

Reported HHS stopgap could open a path to unapproved peptides

A Washington Post report says HHS may allow some restricted peptides to be sold while rules are written. Here is what is confirmed, what is not, and what the evidence looks like.

Peptides in this episode

KPVSemaxEpithalonMOTS-c

This is educational information, not medical advice.